AI Assistant
Blog
Pricing
Log In
Sign Up
An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.